CMT/Tenidap treatment inhibits temporomandibular joint destruction in adjuvant arthritic rats.
State University of New York at Stony Brook 11794-8702.
N
N
Ramamurthy
R
R
Greenwald
S
S
Moak
J
J
Scuibba
A
A
Goren
G
G
Turner
B
B
Rifkin
L
L
Golub
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000503:physiopathology; D018093:Gelatinases / Q000378:metabolism; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D061965:Matrix Metalloproteinase Inhibitors; D000078183:Oxindoles; D011859:Radiography; D051381:Rats; D011917:Rats, Inbred Lew; D013704:Temporomandibular Joint / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D013705:Temporomandibular Joint Disorders / Q000000981:diagnostic imaging / Q000473:pathology / Q000517:prevention & control*; D013752:Tetracycline / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D061965:Matrix Metalloproteinase Inhibitors; D000078183:Oxindoles; C053450:4-des-dimethylaminotetracycline; C062866:tenidap; D018093:Gelatinases; D013752:Tetracycline